Two recent studies suggested that GHSR ablation could even improve aging-associated obesity and insulin resistance in 16–24-month-old mice, potentially by reducing adiposity through improved thermogenic capacity of brown fat and higher lipolytic activity in white adipose tissue [16], [17]. The gene discussed is GHSR; the disease is obesity disorder.